View Author

Tak, P.P.

( P.P. Tak)


treatment villonodular synovitis synovial disease 20 weeks synoviti patient macrophage villonodular infliximab synovium arthritis mri scanning blockade tumour necrosis factor tnfa blockade tumour intra-articular injection tissue intra-articular anti-tnfa intercondylar erosion p p tak 54 weeks cytokine kraan j m g synovial tumour mass synovial tissue smeet rheum pvns .7 8 haemosiderin deposition proinflammatory cytokines erosion baseline control necrosis injection number deposition pathogenesis scanning activity histological factor right knee pigment depositions destruction case report resonance imaging damage haemosiderin neoplastic-like disorder histological features synovial fluid synovial cell netherland reduction amsterdam kroot effusion cartilage destruction expression infliximab treatment disease activity tak pp surgery synovial hyperplasia rheumatology report hyperplasia pigment synovial tissues smeets tj month t hart ba synovial tissue macrophages synovectomy proinflammatory




1 Most Recent Publications

Tumour necrosis factor alpha blockade in treatment resistant pigmented villonodular synovitis (Article)
Kroot, E.J. Kraan, M.C. Smeets, T.J. Maas, M. Tak, P.P. Wouters, J.M.G.W.
2005-01-01